Confluent (CFLT) shares rose about 20% in recent Wednesday trading after several analysts raised their price targets on the stock following the company's forecast-beating Q4 results.
RBC Capital Markets increased its price target on Confluent to $41 from $36 while keeping its outperform rating.
"Confluent reported strong results with all key metrics
ahead of expectations and the high-end of guidance," RBC said in a note. "We feel Confluent is well-positioned for share gains and remains a top SMID-cap idea."
Other price target increases were from Truist to $40 from $35, Oppenheimer to $40 from $37, and UBS to $34 from $26.
Price: 35.99, Change: +5.89, Percent Change: +19.57
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。